JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Начало・Списък с акции・Microbot Medical Inc

Search

Microbot Medical Inc

Затворен

2.09

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.05

Максимум

2.09

Ключови измерители
By Trading Economics
Приходи	113K -3.5M
Служители	43
EBITDA	-561K -4.1M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+257.14% upside

Дивиденти
By Dow Jones
Следващи печалби	12.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-24M 146M
Предишно отваряне	2.09
Предишно затваряне	2.09

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

2.52 / 2.57 Подкрепа & съпротива

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

3.05.2026 г., 23:47 ч. UTC

Печалби

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3.05.2026 г., 22:35 ч. UTC

Печалби

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3.05.2026 г., 23:39 ч. UTC

Пазарно говорене

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3.05.2026 г., 23:34 ч. UTC

Пазарно говорене

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3.05.2026 г., 23:32 ч. UTC

Печалби

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3.05.2026 г., 23:30 ч. UTC

Пазарно говорене

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3.05.2026 г., 23:20 ч. UTC

Пазарно говорене

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3.05.2026 г., 23:16 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3.05.2026 г., 22:57 ч. UTC

Придобивния, сливания и поглъщания

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3.05.2026 г., 22:45 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

3.05.2026 г., 22:45 ч. UTC

Пазарно говорене

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3.05.2026 г., 22:20 ч. UTC

Печалби

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3.05.2026 г., 22:08 ч. UTC

Печалби

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3.05.2026 г., 22:05 ч. UTC

Печалби

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3.05.2026 г., 22:04 ч. UTC

Печалби

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3.05.2026 г., 22:03 ч. UTC

Печалби

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3.05.2026 г., 22:03 ч. UTC

Печалби

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H Cash Earnings A$2.64B>NAB.AU

3.05.2026 г., 22:02 ч. UTC

Печалби

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3.05.2026 г., 22:01 ч. UTC

Печалби

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3.05.2026 г., 15:06 ч. UTC

Печалби

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

257.14% нагоре

12-месечна прогноза

Среден 7.5 USD 257.14%

Висок 12 USD

Нисък 5 USD

Според 3 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

3 ratings

3

Купи

0

Задържане

0

Продай

Според 3 анализатори, дали борсови рейтинги на Microbot Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Други акции от сектора

JNJ

Johnson and Johnson

227.46

UNH

UnitedHealth Group Inc

369.01

TMO

Thermo Fisher Scientific Inc

469.28

ISRG

Intuitive Surgical Inc

457.59

ABT

Abbott Laboratories

89.51

Live chat